G Medical Innovations Holdings Ltd (GMVD) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate G Medical Innovations Holdings Ltd's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
0.00
Strong
WeakModerateStrong
P/B Ratio
0.00
Strong
WeakModerateStrong
Earnings Yield
0.00%
Yield Trap
WeakModerateStrong
Profitability Health
2022Return on Equity
189.83%
Strong
WeakModerateStrong
Operating Margin
-620.14%
Weak
WeakModerateStrong
Net Profit Margin
-315.79%
Weak
WeakModerateStrong
Growth Indicators
2022Revenue Growth
-12.61%
Weak
WeakModerateStrong
Net Income Growth
6.25%
Weak
WeakModerateStrong
EPS Growth
100.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2022Current Ratio
0.22
Weak
WeakModerateStrong
Quick Ratio
0.19
Weak
WeakModerateStrong
Asset Turnover
0.92x
Moderate
WeakModerateStrong
Inventory Turnover
12.45x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-
No data
EV / Free Cash Flow
-0.09x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.06x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.509
Weak
WeakModerateStrong
Return on Invested Capital
11.06%
Weak
WeakModerateStrong
Cash Conversion Cycle
-360.03 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for GMVD.
View Financial Statements